Enliven Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
ELVN
CUSIP
29337E102
Type
Equity
Class
COM
Num filings
184
Total reported value, excl. options
$2.44 B
Manager Report Date Value ($000) Shares Option Type